RiceBran Technologies (RIBT)

[CarlCarlMcB]

Cattle drive xela .80 1.30

[CarlCarlMcB]

Hit back

[copytele]

#56 follow for you , hit me back thank you CARL.

[CarlCarlMcB]

4.00 to 6.00

[CarlCarlMcB]

Merry Christmas $$$$$$$$$weeeeeee

[besdin]

Lucky if the stock dosen't close down for the day

[copytele]

Going for 3 million volumt.

[besdin]

THE NEWS MUST BE OUT SOMEWHERE..probably a buyout..stock should rise to within 10-15 cents of offer price

[copytele]

CRAZY VOLUME

[copytele]

TO THE MOON [RUMORS?]

[copytele]

Your 1st follow~~~~ hit me back please $RIBT

[fr8_train]

Where is Perry Matlock now? Not much movement since he got smoked by the SEC.

[besdin]

stop watching every tick...it all means nothing the company is being sold .87 down .10 this morning

[copytele]

March 17, 2023
10:28 am ET
*RiceBran Tech shares are trading lower after the company reported Q4 financial results.
Benzinga

[copytele]

$1.12 UP

[wow_happens28]

$RIBT Some bigger buy volume coming in at the ask, buyout PR coming soon?

26 to 1 ask over bid

https://ih.advfn.com/stock-market/NASDAQ/ricebran-technologies-RIBT/trades?_ga=2.256236424.2012683222.1554897425-334505475.1554897425

[Fatto]

I am atleast waiting for next CC it's only a month away.

[besdin]

Lotta people gonna make a lotta money buying under a dollar and getting $ 2 buyout...but I wont be one of them...I'll take my $ 175,000 loss and say goodby...great product....but....one incompetent management after another

[copytele]

Many ways to go with this stock~~~~$RIBT

[wow_happens28]

$RIBT Is now the time for RIBT to get an SPAC with a legitimate Chinese company wanting a USA listing? I have no idea if one would work, just a thought.

[wow_happens28]

Or a thought that fits the closing line in the CC, selling each unit individually could get them even more money than selling the company as a whole.?

"These alternatives are at various stages of review"

[wow_happens28]

Or if they could get rid of Dillon they might even make a profit?

[wow_happens28]

$RIBT to be sold or merged? If one reads the last paragraph of the CC it sounds like RIBT is already in a quiet period meaning a deal of some sort is in the works. With management getting paid in warrants priced at "0". and as of last June BOD's getting paid in stock and warrants priced at "0" they certainly want the stock as high as possible. It sounds like if they got rid of Dillon. the company is making a profit. If they could sell it that might be enough. But do they need a quiet period for that?

Last paragraph of the CC>>>>>
Bradley>>>
The Board is in the midst of a strategic review of all the possibilities for RiceBran Technologies. These alternatives are at various stages of review. And given the sensitive nature of this process, I am currently unable to provide any further details. I'd like to thank everybody for their attention, and I'll turn it back to the operator.

https://finance.yahoo.com/news/q4-2022-ricebran-technologies-earnings-093646340.html

[wow_happens28]

$RIBT CC>>>>

https://finance.yahoo.com/news/q4-2022-ricebran-technologies-earnings-093646340.html


Participants
Peter G. Bradley; Executive Chairman & Acting Principal Executive Officer; RiceBran Technologies

Todd Travis Mitchell; COO, CFO & Secretary; RiceBran Technologies

Jeff Stanlis; VP; FNK IR LLC

Presentation
Operator

Greetings, and welcome to the RiceBran Technologies Fourth Quarter and Full Year 2022 Earnings Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. And I will now turn the conference over to your host, Mr. Jeff Stanlis of FNK IR. Sir, the floor is yours.

Jeff Stanlis

Thank you. Good afternoon, everyone, and welcome to the RiceBran Technologies Fourth Quarter 2022 Financial Results Conference Call. Hosting the call today are Peter Bradley, Executive Chairman; and Todd Mitchell, RiceBran's Technologies Chief Operating Officer and Chief Financial Officer.
I want to remind participants that during the call, management's prepared remarks may contain forward-looking statements that are subject to risks and uncertainties. Therefore, the company claims protection under the safe harbor for forward-looking statements as contained in the Private Securities Litigation Reform Act of 1995. Actual results may differ from results discussed today, and therefore, we refer you to a more detailed discussion of these risks and uncertainties in the company's filings with the SEC.
In addition, any projections as to the company's future performance represented by management include estimates as of today, March 16, 2023, and the company assumes no obligation to update these projections in the future as market conditions change.
The webcast and certain financial information provided in the call, including reconciliations of non-GAAP financial measures to comparable GAAP financial measures are available at www.ricebrantech.com on the Investor Relations page. At this time, I would like to turn the call over to Peter. Peter, please go ahead.

Peter G. Bradley

Thank you, Jeff, and good morning -- and good afternoon to everyone. 2022 was a year of both great progress and significant challenges. Notably, we entered into an agreement with Gander Foods with respect to our rice milling operations. And for the first time, Golden Ridge delivered a full quarter of positive contribution to adjusted EBITDA in the fourth quarter.
Additionally, MGI delivered strong revenue and profit contribution growth. Particularly pleasing was the momentum was maintained in the fourth quarter despite challenges with completing a major capital project at the mill. MGI now has 50% more capacity and a broader range of manufacturing capabilities, providing a solid platform for growth.
The Core-SRB business held its own, delivering double-digit revenue growth and maintained its profit contribution. The benefits of the revenue growth and solid pricing action, though, were offset by both higher raw material and operating costs.
While we've been able to grow volume through aggressive sales efforts we were unable to maintain our engagement with the previously disclosed new customers in the pet food category because we were unable to resolve certain technical performance issues.
The added value derivatives business, though had a tough year. The raw material and processing challenges, which materially impacted in the first half of the year, and led to the inability to meet market demand, resulting in customer losses accentuated by increased competition in the derivatives category.
Now let me turn the call over to Todd to discuss the results.

Todd Travis Mitchell

Thank you, Peter. Good afternoon, everyone. We delivered another $10 million plus quarter with year-over-year growth of 32% in the fourth quarter and 34% for the year. Both mills are executing very well and Core-SRB sales grew double digits for 4 quarters in a row. However, while adjusted EBITDA losses declined sequentially and year-over-year in the fourth quarter, largely due to a significant improvement at Golden Ridge. Results were below our expectations for both the quarter and the year.
Looking at the numbers in greater detail. Revenue. Total revenue was $10.6 million in the fourth quarter of 2022, a 32% increase from $8 million in the fourth quarter of 2021. Total revenue was $41.6 million in 2022, a 34% increase from just over $31 million in 2021. Growth for the quarter and for the year was led by Golden Ridge and MGI and helped by double-digit gains in Core-SRB sales offset by a decline in value-add SRB derivative sales.
Gross losses. Gross losses were $87,000 in the fourth quarter of 2022, down from gross losses of $170,000 a year ago. Gross losses were $759,000 for the full year 2022, a $1.2 million decline from gross profits of $442,000 in 2021. Gross losses for the quarter and for the year were driven by a decline in contribution margin from value-add SRB derivative sales. offset in part by improved results from Golden Ridge and MGI.
SG&A. SG&A in the fourth quarter declined 5% to $1.5 million from $1.6 million a year ago. Total SG&A for the year declined 6% to $6.7 million from $7.1 million in 2021. Lower SG&A for the quarter and for the year was driven by a reduction in director compensation and corporate expenses, with the latter primarily due to lower support staff compensation and benefits from subletting our corporate headquarters.
Operating losses. Operating losses declined 71% in the fourth quarter to $1.6 million from operating losses of $5.6 million in the fourth quarter of 2021. Operating losses for the year fell 31% to $7.3 million from $10.6 million in 2021. Operating losses in the fourth quarter and full year of 2021 included $3.9 million in noncash charge for goodwill impairment.
Net losses. Net loss for the quarter was $1.7 million or $0.28 per share compared to a net loss of $5.4 million or $1.04 per share a year ago. Net loss for the full year was $7.9 million or $1.42 per share compared to a net loss of just under $9 million or $1.87 per share in 2021. Net losses in 2021 included a gain of $1.8 million in the first quarter or forgiveness of the SBA PPP loan and the aforementioned $3.9 million charge in the fourth quarter for goodwill impairment.
Adjusted EBITDA. Adjusted EBITDA losses were $654,000 in the fourth quarter compared to adjusted EBITDA losses of $806,000 in the fourth quarter of 2021. Adjusted EBITDA losses for the full year were $3.8 million in the fourth quarter -- I'm sorry, for the full year compared to adjusted EBITDA losses of $2.9 million for 2021.
Lower losses in the fourth quarter stemmed from a significant improvement in contribution from Golden Ridge, while the decline for the year reflected the decline in contribution from our value-add SRB derivatives business.
Cash. Total cash was $3.9 million at the end of the year, down from $5.8 million at the end of 2021 and $4.4 million at the end of the third quarter of 2022. With that, I'll turn the call back to Peter for closing comments.

Peter G. Bradley

Thanks, Todd. Despite the progress in parts of the company in 2022, notably in the rice and specialty milling businesses, the Core-SRB has not moved forward as we wanted it to and the value-added derivatives business continues to suffer major market and operational challenges. Accordingly, we were not able to achieve the goal of positive adjusted EBITDA.
The Board is in the midst of a strategic review of all the possibilities for RiceBran Technologies. These alternatives are at various stages of review. And given the sensitive nature of this process, I am currently unable to provide any further details. I'd like to thank everybody for their attention, and I'll turn it back to the operator.

Operator

Thank you. Ladies and gentlemen, this does conclude today's conference call. You may disconnect your lines at this time, and have a wonderful day, and we thank you for your participation.

[copytele]

50/50 ~~~~report.

[Fatto]

I would take $2 a share lol. Just can't believe they gave no insight/nothing. The stock hasn't moved after hrs. Actually up some?

[wow_happens28]

The sad thing is the company never looked better listening to the Q2 CC. The yeast replacement for the pet food was the bright spot and the downfall when it did not work out. It sure sounded like defeat, either sale or merger is my guess. The stock is not crashing, so guessing any form of BK is not an option.

[confusedtrader]

Terrible management. Over promise and under deliver...

I was taken in by their talk. Bought a massive quantity above the old $1. Biggest loss of my career.

[wow_happens28]

My Q1 is all speculation.

[Fatto]

I never heard nothing on 1Q did I miss that? Wow?

[Fatto]

That was a strange CC I listened to it. 2 of the div are now cash positive but SRV losses. No talk of 1Q just read the numbers and thanks have a good day. Maybe they want to buy cheap shares before all the good news! Lmfao

[wow_happens28]

Book value was listed as $2.50 per share. loss Q4 probably brings it down to like $2.1. plus Q1 is 83% over, more losses.

Sad about the call was Q3, derivatives and Dillon were doing great, now bad? The Q2 call , "We have plenty of cash and probably won't need a reverse split". Can we believe anything they say?

[Fatto]

No I don't, I know its worth a hell of a lot more then 6 million. But you don't get a lot of times book value. I imagine it would go private. Ya, no questions answered no progress provided. That was the first I heard one like that in 7 years.

[confusedtrader]

Looks like a sale of the company is in the works. Any idea what a sale price would be?

[confusedtrader]

Earnings call ended quickly with just a few prepared remarks. No questions were allowed as CEO said company is in the midst of strategic alternatives.

[Fatto]

As hopeful as I want to be that sounded not great and they gave no forward insight. They took no questions.

[confusedtrader]

Link to earnings call starting in a few minutes at 4.30 est

https://www.webcaster4.com/Webcast/Page/2631/47775

[confusedtrader]

Link to earnings press release

https://finance.yahoo.com/news/ricebran-technologies-reports-fourth-quarter-200600055.html?.tsrc=rss

[confusedtrader]

Setbacks in Value-add SRB derivatives weigh on overall results. RiceBran's Value-add SRB derivatives business saw a significant decline in revenue and contribution to adjusted EBITDA in 2022 that offset gains elsewhere. Setbacks in this business were driven by raw material and processing issues which led to inadequate production and resulted in customer losses in the face of new competition.

In light of RiceBran's challenges in achieving its operating and financial targets in 2022, the Company is currently undergoing a strategic review of all the possible alternatives to generate improved returns to its shareholders.

[wow_happens28]

Q over Q 32% revenue increase, loss reduced.

SEC form>>>>>
https://www.sec.gov/Archives/edgar/data/1063537/000143774923006892/ex_489377.htm


story>>>
RiceBran Technologies Reports Fourth Quarter 2022 Results

https://greenstocknews.com/news/nasdaq/ribt/ricebran-technologies-reports-fourth-quarter-2022-results

[Fatto]

I wish I had more faith have been optimistic since 2016. Now I have no expectations hopefully I'm surprised to the good side.

[besdin]

It's too quiet...we're gonna explode one way or the other

[copytele]

NO , JUST BUYING.

[besdin]

YOU'RE RIGHT....MM'S HAVING A FIELD DAY FROM UP .08 TO DOWN .04 ON 24,000 SHARES.. UP ALL DAY UNTIL 3:50p:m WHEN 6000 SHARES DROPPED US .06

[wow_happens28]

Looks like coytele is scalping today, making a fortune off the swings.

[wow_happens28]

Guessing the crooked market makes are shaking people out to buy stock for the next run up. Buy and sell volume were close to even yesterday and the bad Friday had MORE buy volume than sell. Important to close above the 50 day and 100 day. Management owes us a great CC. Virtue did own RIBT, and could still be a marker maker, but IMO, we don't need market makers and they are all potential manipulators, IMO. But earnings beat crooks.>>>>>

https://www.sec.gov/enforce/34-87155-s

Chart>>>
https://stockcharts.com/h-sc/ui?s=RIBT&p=D&yr=0&mn=7&dy=0&id=p84119253858

[wow_happens28]

$RIBT Conference call Thursday 4:30 E.

RiceBran Technologies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on March 16 at 4:30 p.m. EST

https://finance.yahoo.com/news/ricebran-technologies-host-fourth-quarter-121500177.html

TOMBALL, TX / ACCESSWIRE / March 13, 2023 / RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients derived from small and ancient grains for the healthy food, nutraceutical, pet care and animal feed markets, announced that Peter Bradley, Executive Chairman and Todd Mitchell, Chief Financial Officer, will host a conference call on Thursday, March 16, at 4:30 p.m. EST to discuss the Company's financial results for the fourth quarter ended December 31, 2022.

The call information is as follows:

Date: March 16, 2023

Time: 4:30 p.m. Eastern Standard Time

Toll Free Dial-in number for US/Canada: 888-506-0062

Dial-In number for international callers: 973-528-0011

Participant Access Code: 189245

Webcast: https://www.ricebrantech.com/investors

Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on March 16, 2023 until 11:59 p.m. EST on March 30, 2023 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 47775

[besdin]

OOOOPS....THE SELLER IS BACK WITH NO BUYERS AROUND OFF .07

[wow_happens28]

RIBT is in something called a stock market. The small cap index, the Russel 2000 is down 3.4% and maybe 6% the last two days. That often drags other stocks down. I hope like other recent days buyers jump in neat the end of trading.

https://finviz.com/futures_charts.ashx?p=d1&t=ER2

As of 1:04 E. buy volume is about 8/5 buy over sell volume

[besdin]

430 shares at 10:30ish then down 06 on 10,000 sold....drop due to no buyers...seller is gone everyone waiting for conference call